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Abstract
Spatio-temporal activation of Rho GTPases is essential for their function in a variety of biological processes and is achieved
in part by regulating the localization of their activators, the Rho guanine nucleotide exchange factors (RhoGEFs). In this
study, we provide the first characterization of the full-length protein encoded by RhoGEF TEM4 and delineate its domain
structure, catalytic activity, and subcellular localization. First, we determined that TEM4 can stimulate guanine nucleotide
exchange on RhoA and the related RhoB and RhoC isoforms. Second, we determined that TEM4, like other Dbl RhoGEFs,
contains a functional pleckstrin homology (PH) domain immediately C-terminal to the catalytic Dbl homology (DH) domain.
Third, using immunofluorescence analysis, we showed that TEM4 localizes to the actin cytoskeleton through sequences in
the N-terminus of TEM4 independently of the DH/PH domains. Using site-directed mutagenesis and deletion analysis, we
identified a minimal region between residues 81 and 135 that binds directly to F-actin and has an ,90-fold higher affinity
for ATP-loaded F-actin. Finally, we demonstrated that a single point mutation (R130D) within full-length TEM4 abolishes
actin binding and localization of TEM4 to the actin cytoskeleton, as well as dampens the in vivo activity of TEM4 towards
RhoC. Taken together, our data demonstrate that TEM4 contains a novel actin binding domain and binding to actin is
essential for TEM4 subcellular localization and activity. The unique subcellular localization of TEM4 suggests a spatially-
restricted activity and expands the diversity of mechanisms by which RhoGEF function can be regulated.
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Introduction
Rho family GTPases are molecular switches that cycle between
inactive, GDP-bound and active, GTP-bound states [1]. Rho-
GEFs catalyze the exchange of bound GDP for GTP on Rho
GTPases rendering them biologically active to signal to down-
stream effectors. The largest family of RhoGEFs in humans, with
68 human members, is the Dbl family of proteins [2,3], which is
characterized by a tandem catalytic Dbl homology (DH) and
regulatory pleckstrin homology (PH) domain cassette responsible
for accelerating the intrinsic nucleotide exchange activity of one or
more members of the Rho family small GTPases. Together with
DOCK family RhoGEFs, there are over 80 RhoGEFs that can act
on 12 out of 20 Rho GTPases (8 Rho GTPases are predicted or
verified to be constitutively activated and regulated by RhoGEF-
independent mechanisms) [4]. This apparent signaling redundan-
cy is perhaps most striking for activators of RhoA, where at least
24 RhoGEFs have been documented for this single Rho GTPase
[2,3]. Beyond the DH-PH cassette, Dbl family proteins are highly
divergent and possess other interaction motifs or catalytic domains
that account for the distinct mechanisms by which the activity of
Dbl family RhoGEFs is regulated [2]. For example, the Dbl family
RhoGEF, GEF-H1 is sequestered by microtubules through the C-
terminal region of GEF-H1 and its release off the microtubular
lattice promotes the spatial activation of RhoA and changes in the
actin cytoskeleton essential for cellular migration [5–7]. Another
Dbl family RhoGEF, Ect2 is sequestered in the nucleus during
interphase and is released during mitosis to bind the centralspin-
dlin complex to promote spatio-temporal activation of RhoA and
formation of the actin-rich contractile ring that is essential for
cytokinesis [8–10]. Thus, each RhoGEF can integrate distinct
stimulus-dependent, spatio-temporally restricted Rho GTPase
activation which leads to a rearrangement of the actin cytoskeleton
essential for a variety of cellular processes.
In this report, we show that the RhoGEF, TEM4/ARHGEF17
[11], displays a subcellular localization unique amongst RhoGEF
family members as it was associated with actin stress fibers. We
found that TEM4 binds actin directly through a novel actin
binding domain (ABD) within the N-terminus, and the TEM4
ABD is essential for TEM4 localization to the actin cytoskeleton
and the in vivo activity.
Materials and Methods
Expression Constructs, Cell Culture and Reagents
A full-length TEM4/ARHGEF17 (NM_014786) 7.5 kb cDNA
sequence was obtained by subcloning the exon (PCR amplified
from human genomic DNA) encoding the first 456 N-terminal
amino acids into the KIAA0337 clone (Kazusa DNA Research
Institute, Japan) in pBS vector (Stratagene). cDNAs encoding full-
length or truncation mutants of TEM4 were subsequently
subcloned into the pEGFP mammalian expression vector
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(Clontech) and details are available upon request. Point mutations
were introduced by site-directed mutagenesis. An expression
vector encoding a fusion protein Lifeact-tRFP was made by
subcloning cDNA sequences encoding the 17 amino acid actin
binding peptide Lifeact [12] N-terminal to the red fluorescent
protein TagRFP (Evrogen) into the pLL 5.0 lentiviral vector [13].
Antibodies: anti-GST (Sigma), anti-RhoC (Cell Signaling), anti-
GFP (Clontech), anti-b-actin (Sigma), anti-a-tubulin (Sigma), and
anti-TEM4 (ProSci).
Human umbilical vein endothelial cells (HUVECs; Clonetics)
were maintained in EGM-2 supplemented with 10% fetal bovine
serum (FBS; HyClone) and electroporated with expression
constructs using Amaxa Nucleofection technology. NIH3T3 cells
[14] were maintained in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% calf serum and transfected using
Lipofectamine Plus reagent (Invitrogen). 293T cells (ATCC) were
maintained in DMEM supplemented with 10% FBS and
transfected using the calcium phosphate DNA precipitation
method. To visualize the actin cytoskeleton, HUVECs were
transduced with lentivirus expressing tRFP-Lifeact.
Fluorescent Microscopy
Twenty four h after electroporation, HUVECs plated in 35-mm
glass bottom MatTek dishes were examined live using Zeiss LSM
510 or Zeiss Axio Observer spinning disk microscope with an oil
immersion 63x NA 1.4 objective. NIH3T3 cells were transfected
in 35-mm MatTek dishes and examined live using Zeiss LSM 510
within 24 h after transfection.
Protein Purification and Guanine Nucleotide Exchange
Assays
The cDNA fragments encoding residues 81–135 (ABD) or
1050–1478 (DH-PH) of TEM4 was subcloned into pProEx HTb
(Invitrogen) in frame with an N-terminal glutathione S-transferase
(GST) tag. TEM4 protein was expressed in Rosetta BL21 (DE3) E.
coli cells (EMD Biosciences) for 5 h at 25uC, purified on
a glutathione-coupled Sepharose column followed by an S200
size exclusion column (GE Healthcare), and concentrated in buffer
A (20 mM Tris pH 8.0, 200 mM NaCl, 2 mM EDTA, 2 mM
dithiothreitol and 10% glycerol). For some experiments the GST
tag was subsequently removed by incubating GST-TEM4 with
tobacco etch virus protease overnight and then passed over
a glutathione Sepharose column equilibrated in buffer A to
remove the cleaved GST.
To monitor TEM4 catalytic activity, N-methylanthraniloyl
(mant)-GTP incorporation into bacterially-expressed and purified
Rho GTPases was carried out with a FluoroMax-4 spectrometer
(Horiba) at 22uC as described [15]. Two mM of relevant GTPases
were loaded with 400 nM mant-GTP after TEM4 or P-Rex1 DH-
PH domain proteins were added and the relative fluorescence
(lem = 360 nm, lex = 440 nm) was monitored.
Lipid Binding
To assess phosphoinositide binding to the TEM4 PH domain,
PIP Strips (cat # P-6001; Echelon) were blocked with 3% fatty
acid-free bovine serum albumin (Sigma) in phosphate-buffered
saline, and incubated with 1 mg/ml recombinant GST-DH-PH for
1 h at room temperature. The strips were washed and
immunoblotted with anti-GST antibodies.
F-actin Co-sedimentation Assays
To evaluate TEM4 association with F-actin, high-speed actin
co-sedimentation was performed as previously described [16,17].
Briefly, G-actin (APHL99-A; Cytoskeleton) was diluted in G buffer
(5 mM Tris-HCl pH 8, 0.1 mM CaCl2, 0.5 mM DTT, 0.2 mM
ATP), converted to Mg-ATP-G-actin by incubating with 50 mM
MgCl2, 0.2 mM EGTA and polymerized in the presence of
50 mM KCl, 1 mM MgCl2, and 1 mM ATP for 1 h at room
temperature. GST-TEM4 was incubated with F-actin at room
temperature for 30 min, and sedimented using an Airfuge
(Beckman) at 23 psi (,100,0006g) for 30 min. Supernatant and
pellet fractions were solubilized in SDS sample buffer and resolved
by SDS-PAGE. To calculate the binding affinity of TEM4 to F-
actin, the supernatant-depletion method [17,18] was used. The
amount of TEM4 bound to F-actin was determined indirectly by
immunoblotting the supernatant with anti-GST antibodies and
quantified by densitometry. All blots were within the linear range
of detection as determined by running out a range of GST-TEM4
protein dilutions (unpublished data). For experiments with ADP-
G-actin, ATP-G-actin was converted to ADP-G-actin with 20 U/
mL hexokinase (Sigma) and 1 mM glucose for 3 h at 4uC as
previously described [16,19] and used immediately.
Immunoprecipitation Analysis
HUVEC were left untreated or preincubated with 1 mM LatA
(Sigma) for 30 min and lysed in immunoprecipitation buffer
(10 mM PIPES, pH 7, 100 mM KCl, 2 mM EDTA, 0.5% Triton
X-100) containing protease inhibitors. Cell lysates were incubated
with TEM4 antibody, precoupled to protein G Dynabeads
(Invitrogen), for 4 h at 4uC. The beads were washed with the
immunoprecipitation buffer four times and immunocomplexes
were analyzed by immunoblotting.
RhoC Activation Pull-down Assays
The pGEX construct encoding a GST fusion protein of the Rho
binding domain (RBD) of Rhotekin (amino acids 7–89) (provided
by Keith Burridge, UNC-Chapel Hill) was used for expression in
bacteria and GST-Rhotekin-RBD was purified from bacterial cell
lysates using glutathione-Sepharose 4B beads (Amersham Bios-
ciences). Transiently transfected 293T cells were maintained in
growth medium for 24 h and then serum-starved (0.5% FBS)
overnight. Cells were lysed in lysis buffer (50 mM Tris, pH 7.5,
500 mM NaCl, 10 mM MgCl2, 1% Triton X-100, 10% glycerol)
supplemented with protease inhibitors and pelleted at 13,0006g
for 5 min. Thirty mg of GST-Rhotekin-RBD immobilized on
glutathione-Sepharose 4B beads were incubated with 500 mg of
clarified cell lysates for 1 h at 4uC. The beads were washed twice
in wash buffer (25 mM Tris, pH 7.5, 40 mM NaCl, 30 mM
MgCl2). Whole cell lysates and affinity-precipitated samples were
subjected to SDS-PAGE and analyzed by western blotting using
RhoC isoform-specific antibodies.
Results
TEM4 is a Rho-specific RhoGEF
TEM4/ARHGEF17 is a member of the Dbl family of
RhoGEFs [2] as it possesses a tandem Dbl homology (DH) and
pleckstrin homology (PH) domain catalytic cassette. TEM4 was
annotated by St. Croix et al. [11] and encodes a 2063 amino acid
protein with a predicted molecular weight of 222 kDa that, in
addition to the DH and PH domains, contains extensive N-
terminal sequences (residues 1–1064) with no predicted domains
or motifs, and a C-terminal domain with a predicted seven-bladed
b-propeller fold (residues 1469–2063) (Fig. 1A). Subsequently,
another study reported on a 1510 amino acid protein encoded by
TEM4, which they called p164-RhoGEF based on a predicted
molecular weight of 164 kDa [20]. The p164-RhoGEF cDNA
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sequence was presumed to be full-length based on available EST
clone data (KIAA0337). However, our additional EST sequence
analyses determined that p164-RhoGEF is an N-terminal trunca-
tion of TEM4 sequence as originally annotated by St Croix et al.,
and this is now reflected in public DNA databases. We have
further validated full-length TEM4 protein expression by western
Figure 1. TEM4 is a Rho-specific guanine nucleotide exchange factor. A, A schematic representation of the domain structure of TEM4. TEM4
encodes a 2063 amino acid protein that, in addition to the DH and PH domains, contains extensive N-terminal sequences (residues 1-1059) with no
identifiable domains or motifs, and a C-terminal domain containing a predicted b-propeller fold (residues 1723–2039) likely consisting of seven
WD40-related repeats [24,60,61]. The PH domain is split by an ,60 amino acid a-helical insert. B, TEM4 is expressed in mammalian cell lines of
endothelial and non-endothelial cell lineage. C–G, Guanine nucleotide exchange of RhoA (C), RhoB (D) or RhoC (E) (2 mM) was assessed in the
presence (red trace) or absence (black trace) of the isolated DH-PH domain of TEM4 (10 nM). Guanine nucleotide exchange of Rac1 (F) and Cdc42 (G)
(2 mM) was assessed in the presence of the DH-PH domains of TEM4 (50 nM; red trace) and PREX1 (200 nM; green trace). Intrinsic activities of Rac1
and Cdc42 are shown as a black trace. Arrows indicate time of GEF addition. Data shown are representative of three independent experiments. Five
mg of each protein used in GEF assays were resolved by SDS-PAGE and visualized by Coomassie Blue dye (inset D). H, Structure-based sequence
alignment of the TEM4 PH domain. A homology model of the PH domain of TEM4 (residues 1286–1476) was generated using the protein homology/
analogy recognition engine2 (Phyre2) structure prediction server and then structurally aligned with the determined structures of DH-associated PH
domains from SOS1 (PDB: 1AWE) [62], TIAM1 (PDB: 1FOE) [63] and TRIO (PDB: 1NTY) [64] using the Vector Alignment Search Tool (VAST) [65]. The
assignments of beta strands (blue arrows, b1–b7) and the C-terminal a-helix (yellow cylinders, aC) are shown for each PH domain sequence.
Secondary structure analysis predicts a ,70 residue a-helical region (red) is inserted in the b5/b6 turn of the TEM4 PH domain. Residues within TEM4
likely utilized for phospholipid binding are marked (arrowheads). A highly conserved tryptophan residue within aC of PH domains (phenylalanine in
TEM4 and Tiam1) is indicated (star). Dots mark every 10th residue. I, Protein-lipid overlay assay. Purified GST-DH-PH fusion protein was incubated with
a lipid array and then detected with an anti-GST antibody. LPA, lysophosphatidic acid; LPC, lysophosphocholine; PC, phosphatidylcholine; PS,
phosphatidylserine; PA, phosphatidic acid; PE, phosphatidylethanolamine; S1P, sphingosine 1-phosphate; PI, phosphatidylinositol; PI(3)P,
phosphatidylinositol 3-phosphate; PI(4)P, phosphatidylinositol 4-phosphate; PI(5)P, phosphatidylinositol 5-phosphate; PI(3,4)P2, phosphatidylinositol
3,4-biphosphate; PI(3,5)P2, phosphatidylinositol 3,5-biphosphate; PI(4,5)P2, phosphatidylinositol 4,5-biphosphate; PI(3,4,5)P3, phosphatidylinositol
3,4,5-triphosphate.
doi:10.1371/journal.pone.0041876.g001
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blot analysis with antibodies raised against epitope shared between
TEM4 and p164-RhoGEF proteins. Consistent, with the current
curated NCBI annotation, expression of only the full-length,
p222 kDa TEM4 protein was detected in multiple human and
rodent cell lines (Fig. 1B), confirming that the sequence of TEM4
used in this report constitutes the authentic full-length TEM4.
To determine the specificity profile of TEM4 towards Rho
GTPases, a bacterially expressed DH-PH fragment of TEM4
(residues 1050–1478) was used in fluorescent-based GEF assays in
vitro [15] using bacterially expressed recombinant Rho GTPases
(Fig. 1C–G). In this assay, TEM4 accelerated the intrinsic guanine
nucleotide exchange rate of RhoA, as previously shown [20,21],
and the closely related RhoB and RhoC isoforms (Fig. 1C–E), but
not Rac1 or Cdc42 (Fig. 1F, G). The Rac1 and Cdc42 proteins
were functional as shown by their ability to be stimulated by the
isolated DH-PH domains of P-Rex1 [22]. These data demonstrate
that the catalytic activity of TEM4 is specific for RhoA/B/C in
vitro.
Finally, the presence of a PH domain C-terminal to the DH
domain of TEM4 was put into question by a previous study [20].
Indeed, conventional domain prediction and annotation based
solely on primary sequence alignment, such as is performed by the
Simple Modular Architecture Research Tool (SMART) [23] does
not identify a PH domain in TEM4 with statistical significance.
However, three-dimensional structure prediction algorithms,
which more reliably identify remote homologous sequences,
readily detect a PH domain within TEM4 residues 1286–1476
(Fig. 1A, H). For example, the Phyre2 web server predicts a TEM4
PH domain with 99.4% confidence [24]. The Phyre2 generated
PH domain homology model reveals that an ,70 residue a-helical
domain (aa 1366–1433) is inserted in the b5/b6 turn of the TEM4
PH domain. Furthermore, residues Arg 1306, Lys 1321 and Lys
1348 within the PH domain are likely to participate in forming
a functional phospholipid binding site. To assess the ability of the
PH domain of TEM4 to bind phosphoinositides [25], we
performed lipid dot blot analyses using bacterially expressed
GST-DH-PH fusion protein. We found that the TEM4 DH-PH
domains bound primarily PI(3)P, PI(4)P and PI(5)P (Fig. 1I). Since
DH domains do not characteristically bind phosphoinositides
Figure 2. N-terminus of TEM4 is essential for localization of TEM4 to cytoskeleton. A, Endogenous TEM4 associates with F-actin. TEM4 was
immunoprecipitated from HUVECs pretreated with LatA and b-actin was detected by western blotting. B, Schematic of GFP-TEM4 fusion constructs.
DH, Dbl homology; PH, pleckstrin homology. C, The N-terminus of TEM4 possesses the actin association signal. HUVECs were electroporated with GFP
or GFP-tagged TEM4 constructs as indicated and imaged live. Scale bar, 20 mm.
doi:10.1371/journal.pone.0041876.g002
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[26,27], these results support the presence of a functional PH
domain within TEM4.
The N-Terminus of TEM4 Regulates Subcellular
Localization
Our initial studies aimed at determining interacting partners of
TEM4 found actin to co-immunoprecipitate with exogenously
expressed TEM4 (unpublished data). To confirm the TEM4-actin
association, we immunoprecipitated endogenous TEM4 from
primary human endothelial cells (HUVECs) that were left
untreated or treated with an actin depolymerizing drug,
latrunculin A (LatA) [28] prior to immunoprecipitation. As shown
in Fig. 2A, endogenous TEM4 readily co-immunoprecipitated
with actin, but the interaction was ablated in cells treated with
LatA. Therefore, we concluded that TEM4 associates with F-actin
filaments in vivo.
To investigate the association of TEM4 with F-actin further, the
subcellular localization of full-length (FL) and truncated forms of
TEM4 (Fig. 2B) was examined in live HUVECs. FL TEM4 (GFP-
FL) resided on structures reminiscent of the actin cytoskeleton
throughout the cytoplasm (Fig. 2C). HA-tagged FL TEM4
exhibited similar localization (unpublished data). Furthermore,
while the deletion of the region C-terminal to the PH domain
(GFP-DC) did not alter TEM4 localization, N-terminally deleted
TEM4 (GFP-DN) and the isolated DH/PH domains (GFP-DH/
PH) exhibited a diffuse cytoplasmic staining. These results suggest
that sequences within the N-terminal portion of TEM4 are
required for localization. Indeed, a construct encoding the first 582
N-terminal amino acids of TEM4 localized to the actin
cytoskeleton (Fig. 2C). Therefore, sequences within the N-terminal
region of TEM4 (residues 1–582) are necessary and sufficient for
the subcellular localization of TEM4.
Figure 3. Detailed mapping of actin-association domain of TEM4. A, GFP-TEM4 fusion constructs encoding various truncations of the N-
terminus or GFP were transfected into NIH3T3 cells and imaged live. Scale, 20 mm. B, The newly identified actin-binding domain of TEM4 (aa 81–135
in human TEM4) is conserved among TEM4 orthologs. Helices (H) predicted by the secondary structure prediction server PredictProtein [66] are
labeled.
doi:10.1371/journal.pone.0041876.g003
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To identify the minimal domain required for the association
with F-actin in vivo, we performed extensive deletion mutagenesis
and identified a region encompassing residues 80–135 that
exhibited cellular localization similar to TEM4 1–582 (Fig. 3A).
The 81–135 region of human TEM4 is highly conserved within
TEM4 orthologs (Fig. 3B), but does not exhibit sequence similarity
to known actin-binding domains [29–31]. Therefore, TEM4 81–
135 is sufficient for localization to the actin cytoskeleton in vivo and
may constitute a novel actin binding domain (ABD).
TEM4 Binds F-actin Through the Novel Actin-Binding
Domain
To determine if the association of TEM4 with F-actin is direct,
we purified recombinant GST-TEM4 81–135 (GST-ABD) and
evaluated its ability to bind purified F-actin using a high-speed
actin co-sedimentation assay. Recombinant GST-ABD was found
predominantly in the F-actin-containing pellet (p) only in the
presence of F-actin (Fig. 4A). The stoichiometry of GST-ABD
binding to F-actin was estimated to be 1:1.4 (Fig. 4B). However,
when we accounted for the 15–20% GST cleavage product
present in the GST-ABD protein sample, the stoichiometry came
close to a 1:1 ratio. The specificity of interaction between TEM4
ABD and F-actin was further confirmed by co-sedimentation of F-
actin with the untagged TEM4 ABD (Fig. 4C). These data
demonstrate that sequences within TEM4 81–135 comprise a high-
affinity ABD.
In a cell, newly polymerized, dynamic actin filaments are
composed mainly of ATP- and ADP-Pi–actin [32], while mature
filaments are composed primarily of ADP-actin [33,34]. The
Figure 4. TEM4 binds directly to F-actin with high affinity. A, Binding of TEM4 (residues 81–135) to F-actin was examined by actin co-
sedimentation assays. Recombinant GST-TEM4 protein was incubated with F-actin and subjected to high speed centrifugation. Soluble (s) and pellet
(p) fractions were resolved by SDS-PAGE and stained with Coomassie Blue. B, Coomassie Blue-stained gel showing the near-saturation binding of
GST-TEM4-ABD to F-actin. Numbers below protein bands indicate protein concentrations in mM as determined by densitometry. C, TEM4 ABD binds
F-actin. Silver stained gel shows co-sedimentation of untagged TEM4 ABD with F-actin. D-G, TEM4 preferentially binds dynamic ATP/ADP-Pi-F-actin.
ATP- or ADP-bound G-actin was polymerized and binding of the resulting F-actin filaments to GST-ABD was determined by co-sedimentation analysis.
Representative Coomassie Blue-stained gels showing amount of ATP/ADP-Pi- or ADP-F-actin in the pellet of co-sedimentation experiment (D and E,
top panel). Immunoblot showing amount of GST-ABD protein left in the supernatant in co-sedimentation experiments (bottom panel). F, G,
Equilibrium binding of GST-ABD to ATP/ADP-Pi- or ADP-F-actin. Amount of GST-ABD bound to F-actin was calculated from immunoblots similar to the
ones shown in D and E.
doi:10.1371/journal.pone.0041876.g004
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nucleotide state of actin affects its interaction with actin binding
proteins and affects kinetics of actin assembly and disassembly
[17,19,34]. To determine if binding of TEM4 ABD to actin is
dependent on the nucleotide state of actin, actin co-sedimentation
assays were repeated using F-actin assembled from ATP- or ADP-
G-actin. After ultracentrifugation, the amount of TEM4 bound to
F-actin filaments was calculated from the amount depleted from
the supernatant as detected by immunoblotting and densitometry
(Fig. 4D, E). The data show that TEM4 ABD has a strong
preference for binding dynamic F-actin, as it exhibited an
approximately 90–fold higher affinity for filaments prepared from
ATP-G-actin than those prepared from ADP-G-actin (Kd
= 53 nM and 4.7 mM, respectively; Fig. 4F, G). This affinity of
the TEM4 ABD for ATP-F-actin is comparable to that measured
for the actin nucleating complex, Arp2/3 which is 40 nM [35].
Taken together, these data demonstrate that TEM4 contains an
ABD which binds preferentially to dynamic, newly assembled
actin filaments.
Deletion of an 11 amino acid segment (residues 125–135) within
the TEM4-ABD ablated the localization of TEM4 to the actin
cytoskeleton in vivo (Fig. 3A). Therefore, it is highly probable that
specific residues within 125–135 (Fig. 5A) contribute important
interactions required for the high affinity binding of TEM4 to
actin filaments. To identify individual residues essential for TEM4
binding to F-actin, we performed site-directed mutagenesis and
determined the subcellular localization of these point mutants.
Consistent with experimental data in other actin binding proteins
where a positively charged surface was required for actin binding
[36], mutation of the conserved R130 in TEM4 mislocalized GFP-
TEM4 (Fig. 5B) and abolished the ability of GST-TEM4-ABD to
co-sediment with ATP/ADP-Pi actin, suggesting that the R130 is
critical for high affinity binding between TEM4 and F-actin
(Fig. 5C, D).
Arg 130 is Essential for TEM4 Subcellular Localization and
In vivo Activity
We found that the N-terminus of TEM4 regulates its subcellular
localization and R130 is essential for F-actin binding of the
isolated ABD of TEM4 in vitro. To determine if actin binding is
essential for the subcellular localization of FL TEM4 to the actin
cytoskeleton, GFP-FL TEM4 WT or the R130D mutant were
expressed in HUVECs together with the fluorescently-tagged
(tRFP) actin marker, Lifeact, to visualize the actin cytoskeleton
[12]. As shown in Fig. 6A, colocalization of GFP-FL TEM4 WT
with the actin cytoskeleton was abolished by the introduction of
Figure 5. Arg 130 in TEM4 ABD is essential for F-actin binding. A, Alignment of residues 125-135 of human TEM4 with other species. Residues
tested for actin binding in vivo are marked with a dot above the alignment. The arginine residue (R130), that we determined to be critical for binding
to F-actin, is marked with the asterisk. B, Wild-type and point mutants of GFP-TEM4 1-582 were used to further map residues essential for actin
association in vivo in live NIH3T3 cells. C, Coomassie Blue-stained gel comparing ATP/ADP-Pi-F-actin binding capacity of wild-type (WT) and R130D
mutant of GST-ABD in co-sedimentation experiments. D, Equilibrium binding of WT and R130D mutant of TEM4 ABD to ATP/ADP-Pi-F-actin calculated
from co-sedimentation experiments as shown in Fig. 4. Two independent co-sedimentation experiments were used to generate the data.
doi:10.1371/journal.pone.0041876.g005
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the R130D mutation into TEM4. These data suggest that TEM4
contains a single ABD and that F-actin binding is essential for
subcellular localization of TEM4 in vivo.
The subcellular localization of RhoGEFs may potentiate the
activation of downstream Rho GTPases [2]. Therefore, we
determined if the localization of TEM4 to the actin cytoskeleton
modulates the in vivo activity of TEM4. We found that
mislocalization of TEM4 to the cytosol by either amino-terminal
deletion or mutation of R130 in the full-length protein severely
reduced the ability of TEM4 to activate its substrate, RhoC, as
compared to TEM4 WT (Fig. 6B–D). These data suggest that
binding to F-actin, which is required for subcellular localization of
TEM4, regulates TEM4 activity in vivo.
Discussion
In this study, we characterized the RhoGEF, TEM4/ARH-
GEF17 and demonstrated that it exhibits a subcellular localization
distinct among RhoGEFs facilitated by direct binding to F-actin
through a novel actin binding domain. Furthermore, we found
that disruption of TEM4 binding to actin caused an altered
subcellular localization and impaired its in vivo activity. We suggest
Figure 6. Actin binding is essential for subcellular localization and in vivo activity of TEM4. A, R130 is essential for the localization of TEM4
to actin stress fibers. HUVECs expressing GFP, GFP-FL TEM4 WT or R130D mutant were imaged live with tRFP-Lifeact marker. Scale bar, 10 mm. B, The
N-terminus is essential for TEM4 in vivo activity. HUVECs expressing GFP-tagged TEM4 constructs were assessed for levels of active RhoC by affinity
pull-down. C, Mutation of R130 impairs RhoC activation by TEM4. 293T cells were transfected with GFP-tagged wild-type or R130D mutant of TEM4
and levels of active RhoC were measured by affinity pull-down and presented in a bar graph (D). Data shown are representative of three independent
experiments.
doi:10.1371/journal.pone.0041876.g006
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that this unique subcellular localization allows TEM4 to serve
a highly distinct spatially-restricted role in regulating activation of
Rho GTPases and therefore biological function.
RhoGEFs are large proteins distinguished by a unique set of
protein and/or lipid interaction domains and motifs, outside of the
shared DH-PH domains, that regulate function of RhoGEFs [2].
TEM4 possesses an actin binding domain (ABD) within the N-
terminus (residues 81–135) that binds F-actin with high affinity.
Our extensive analysis of the ABD using primary sequence
analysis and secondary structure prediction algorithms failed to
identify similarity to any known ABDs. A novel actin binding
domain was previously reported in two other RhoGEFs, PDZ-
RhoGEF and frabin [37,38] and L/IIxxFE motif within these
proteins was essential for binding to F-actin [39]. Interestingly,
despite the lack of the overall sequence homology, TEM4 contains
an LSxxFD motif within the N-terminus of the ABD; however, our
studies suggest that the C-terminal residues are the most critical for
TEM4 binding to F-actin. Regardless of the lack of primary
sequence homology between the TEM4 ABD and known actin
binding proteins, secondary structure prediction analysis suggests
the presence of several helices (Fig. 3B) as common amongst ABDs
[29–31,40]. Finally, the ABD-containing region is absent from the
two closely-related TEM4 family members, ARHGEF10 and
ARHGEF10L/GrinchGEF [41,42]. Therefore, we demonstrate
that TEM4 contains a novel ABD and future studies are needed to
characterize how TEM4 may affect actin filament dynamics.
Exogenous, GFP- or HA-tagged TEM4 readily decorated the
entire length of actin stress fibers in HUVECs and endogenous
TEM4 immunoprecipitates with F-actin. However, our in vitro
actin-binding analysis found TEM4 ABD preferentially bound
newly polymerized actin filaments, suggesting that TEM4 may
associate with F-actin in the areas of the cell undergoing actin
polymerization, e.g. leading edge, as shown for other actin-binding
proteins with in vitro preference for ATP-F-actin [43–45].
Therefore, while the use of exogenously-expressed constructs was
instrumental in mapping the ABD, the overexpressed protein may
not accurately display the subcellular localization of endogenous
TEM4. Thus, an important goal for our future studies will be an
evaluation of the subcellular localization of endogenous TEM4.
Our data using affinity pull-down assays suggest that binding to
actin regulates TEM4-induced activation of its Rho GTPase
substrates. This could be achieved by at least two mechanisms.
First, the ability of TEM4 to bind F-actin can result in recruitment
and concentration of TEM4 at the sites of actin polymerization
where Rho GTPases are known to be activated [46]. Second, like
many other RhoGEFs [2], TEM4 may be auto-inhibited and ABD
association with F-actin could relieve this autoinhibition, leading
to enhanced intrinsic GEF activity similar to microtubular-
mediated regulation of GEF-H1 [5]. Both of these scenarios
would result in pools of active TEM4 localized in the areas
undergoing actin polymerization where activation of Rho
GTPases would be the most desirable to promote further
cytoskeleton rearrangements.
Rho family GTPases are key regulators of actin cytoskeleton
dynamics and proteins of Rho subfamily (RhoA, B, C) promote
the formation of actin stress fibers [47–49] that are essential for
a diversity of cellular processes, including cell shape, polarity,
migration, cell-cell and cell-matrix interactions [47,50,51]. We
have observed increased Rho GTPase activation and actin
rearrangement in cells expressing WT and not the actin
binding-deficient, R130D mutant of TEM4 (Fig. 6). These
observations suggest that targeted localization of the catalytic
activity of TEM4 may be critical for the subsequent actin
rearrangement, which is essential for cellular functions of Rho
GTPases such as cell migration and invasion [46,52–54]. To our
knowledge, this is the first report of the actin cytoskeleton-
dependent regulation of an in vivo activity of a RhoGEF.
Rho GTPases interact with a diverse spectrum of downstream
effectors and can regulate a diversity of cellular processes [55].
While RhoGEFs are best characterized for their abilities to
facilitate Rho GTPase activation, there is also considerable
evidence that RhoGEFs can influence the effector signaling
output of their Rho GTPase substrates. One mechanism involves
the restricted spatial activation of Rho GTPases [46], thereby
leading to differential engagement and utilization of specific
effectors. Another mechanism involves the function of RhoGEFs
as a scaffold that can recruit effectors to promo-te differential
effector utilization and signaling output [56,57]. Interestingly,
while the C-terminus of TEM4 was not required for subcellular
localization, it is homologous to a region found in JSAP-1/JIP-3,
a known scaffold for the c-Jun N-terminal kinase pathway [58,59].
Future studies will determine if TEM4 promotes spatial activation
of distinct effector pathways downstream of Rho GTPases and the
mechanism of the preferential engagement of these pathways.
In conclusion, RhoGEF TEM4 binds F-actin through a novel
actin binding domain and actin binding is essential for TEM4
subcellular localization and an in vivo activity. Future studies
include regulation of TEM4-actin interaction and the biological
consequences of actin-localized TEM4-Rho GTPase signaling.
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